marketnews

Breaking Barriers: Myriad Genetics Teams Up with Institut für Hamopathologie Hamburg and Centre Georges-François Leclerc to Bring Genetic Testing to Europe

Collaboration brings MyChoice CDx Plus Testing to Hamburg, Germany and Dijon, France Latest expansions represent Myriad’s commitment to growing international lab partner program Myriad Genetics, Inc., a leader in genetic testing and precision medicine, has announced two new partnerships with renowned medical institutions in Hamburg, Germany and Dijon, France. These collaborations will bring MyChoice CDx…

Read More

Blue Water Vaccines: A Look at Second Quarter 2022 Financial Results and Recent Business Highlights

Blue Water Vaccines Reports Second Quarter 2022 Financial Results and Recent Business Highlights Closed Private Placement and Strategic Agreements In April 2022, Blue Water Vaccines Inc. successfully closed a private placement, raising approximately $6.9 million in net proceeds. This injection of capital will bolster the company’s research, development, and manufacturing efforts for its innovative vaccine…

Read More

China’s Latest Economic Report: A Tale of Disappointment and Surprising Developments

China’s Latest Economic Report: A Tale of Disappointment and Surprising Developments Overview Equities were mostly higher in the Asia Pacific region, though Chinese and Hong Kong markets eased, and South Korea and India were closed for national holidays. Despite new Chinese exercises off the coast of Taiwan following another US congressional visit, Taiwan’s Taiex gained…

Read More

Navios Maritime Holdings, Inc. Announces Full Satisfaction and Discharge of 11.25% Senior Secured Notes Due 2022

Navios Maritime Holdings Inc. Announces Satisfaction and Discharge of Indenture Governing 11.25% Senior Secured Notes GRAND CAYMAN, Cayman Islands, Aug. 12, 2022 (GLOBE NEWSWIRE) — Navios Maritime Holdings Inc. (“Navios Holdings” or the “Company”) (NYSE: NM), a global seaborne shipping and logistics company, announced today that on August 11, 2022, the Company satisfied and discharged…

Read More

Receive Daily Inspiration Straight to Your Inbox: Unlocking Valuable Insights for Your Trading Journey

The Influence of Brent Donnelly’s am/FX Introduction Brent Donnelly’s am/FX is a highly regarded resource in the global markets community, providing valuable insights on a daily basis. His in-depth analysis on various topics related to global markets has gained him a loyal following among traders and investors. What am/FX Covers Brent covers a wide range…

Read More

Unleashing the Crypto Craze: A Chat with Choisecom’s CEO on Curating the Ultimate Crypto Experience

MetaFi: The Future of Finance? A Conversation with Vladmir Gorbunov From CeFi to DeFi: The Evolution of Choise.com Welcome, readers, to another exciting installment of Finance Magnates interviews! Today, we have the pleasure of sitting down with Vladimir Gorbunov, the dynamic CEO of Choise.com. If you’re not familiar with Choise.com, let me break it down…

Read More

Guardion Health Sciences: A Look at Financial Results for Q2 2022

Guardion Health Sciences Announces Highest Quarterly Revenue in Company History Viactiv® Product Line Drives Growth Guardion Health Sciences, Inc. (Nasdaq: GHSI) has reported record-breaking revenue of approximately $3.275 million for the most recent quarter. This marks a significant increase from the previous quarter and showcases the company’s continued growth and success in the market. Company…

Read More